[en] BACKGROUND: The clinical significance of 16p13.11 duplications remains controversial while frequently detected in patients with developmental delay (DD), intellectual deficiency (ID) or autism spectrum disorder (ASD). Previously reported patients were not or poorly characterised. The absence of consensual recommendations leads to interpretation discrepancy and makes genetic counselling challenging. This study aims to decipher the genotype-phenotype correlations to improve genetic counselling and patients' medical care. METHODS: We retrospectively analysed data from 16 013 patients referred to 12 genetic centers for DD, ID or ASD, and who had a chromosomal microarray analysis. The referring geneticists of patients for whom a 16p13.11 duplication was detected were asked to complete a questionnaire for detailed clinical and genetic data for the patients and their parents. RESULTS: Clinical features are mainly speech delay and learning disabilities followed by ASD. A significant risk of cardiovascular disease was noted. About 90% of the patients inherited the duplication from a parent. At least one out of four parents carrying the duplication displayed a similar phenotype to the propositus. Genotype-phenotype correlations show no impact of the size of the duplicated segment on the severity of the phenotype. However, NDE1 and miR-484 seem to have an essential role in the neurocognitive phenotype. CONCLUSION: Our study shows that 16p13.11 microduplications are likely pathogenic when detected in the context of DD/ID/ASD and supports an essential role of NDE1 and miR-484 in the neurocognitive phenotype. Moreover, it suggests the need for cardiac evaluation and follow-up and a large study to evaluate the aortic disease risk.
Disciplines :
Genetics & genetic processes
Author, co-author :
Allach El Khattabi, Laila
Heide, Solveig
CABERG, Jean-Hubert ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Unité de laboratoire - neurogénétique
Hannes, F.D., Sharp, A.J., Mefford, H.C., De Ravel, T., Ruivenkamp, C.A., Breuning, M.H., Fryns, J.P., Vermeesch, J.R., Recurrent reciprocal deletions and duplications of 16p13.11: The deletion is a risk factor for Mr/Mca while the duplication may be a rare benign variant (2009) J Med Genet, 46, pp. 223-232
Ullmann, R., Turner, G., Kirchhoff, M., Chen, W., Tonge, B., Rosenberg, C., Field, M., Ropers, H.H., Array cgh identifes reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation (2007) Hum Mutat, 28, pp. 674-682
Nagamani, S.C., Erez, A., Bader, P., Lalani, S.R., Scott, D.A., Scaglia, F., Plon, S.E., Cheung, S.W., Phenotypic manifestations of copy number variation in chromosome 16p13.11 (2011) Eur J Hum Genet, 19, pp. 280-286
Ramalingam, A., Zhou, X.G., Fiedler, S.D., Brawner, S.J., Joyce, J.M., Liu, H.Y., Yu, S., 16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders (2011) J Hum Genet, 56, pp. 541-544
Delicado, A., Fernández, L., De Torres, M.L., Nevado, J., García-Santiago, F.A., Rodríguez, R., Mansilla, E., De, T.M.L., Familial imbalance in 16p13.11 leads to a dosage compensation rearrangement in an unaffected carrier (2014) BMC Med Genet, 15, p. 116
Rosenfeld, J.A., Coe, B.P., Eichler, E.E., Cuckle, H., Shaffer, L.G., Estimates of penetrance for recurrent pathogenic copy-number variations (2013) Genet Med, 15, pp. 478-481
Kuang, S.Q., Guo, D.C., Prakash, S.K., McDonald, M.L., Johnson, R.J., Wang, M., Regalado, E.S., Milewicz, D.M., Recurrent chromosome 16p13.1 duplications are a risk factor for aortic dissections (2011) PLoS Genet, 7, p. e1002118. , investigators g. genTac investigators
Tropeano, M., Ahn, J.W., Dobson, R.J., Breen, G., Rucker, J., Dixit, A., Pal, D.K., Collier, D.A., Male-biased autosomal effect of 16p13.11 copy number variation in neurodevelopmental disorders (2013) PLoS One, 8. , e61365
Stefansson, H., Meyer-Lindenberg, A., Steinberg, S., Magnusdottir, B., Morgen, K., Arnarsdottir, S., Bjornsdottir, G., Stefansson, K., CnVs conferring risk of autism or schizophrenia affect cognition in controls (2014) Nature, 505, pp. 361-366
Girirajan, S., Rosenfeld, J.A., Coe, B.P., Parikh, S., Friedman, N., Goldstein, A., Filipink, R.A., Eichler, E.E., Phenotypic heterogeneity of genomic disorders and rare copy-number variants (2012) N Engl J Med, 367, pp. 1321-1331
Mefford, H.C., Sharp, A.J., Baker, C., Itsara, A., Jiang, Z., Buysse, K., Huang, S., Eichler, E.E., Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes (2008) N Engl J Med, 359, pp. 1685-1699
Yan, X., Li, F., Liang, Y., Shen, Y., Zhao, X., Huang, Q., Zhu, X., Human nudel and nude as regulators of cytoplasmic dynein in poleward protein transport along the mitotic spindle (2003) Mol Cell Biol, 23, pp. 1239-1250
Houlihan, S.L., Feng, Y., The scaffold protein nde1 safeguards the brain genome during s phase of early neural progenitor differentiation (2014) Elife, 3, p. e03297
Fujitani, M., Zhang, S., Fujiki, R., Fujihara, Y., Yamashita, T., A chromosome 16p13.11 microduplication causes hyperactivity through dysregulation of mir-484/protocadherin-19 signaling (2017) Mol Psychiatry, 22, pp. 364-374
Zhu, L., Vranckx, R., Khau Van Kien, P., Lalande, A., Boisset, N., Mathieu, F., Wegman, M., Jeunemaitre, X., Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus (2006) Nat Genet, 38, pp. 343-349
Glancy, D.L., Wegmann, M., Dhurandhar, R.W., Aortic dissection and patent ductus arteriosus in three generations (2001) Am J Cardiol, 87, pp. 813-815
Pannu, H., Tran-Fadulu, V., Papke, C.L., Scherer, S., Liu, Y., Presley, C., Guo, D., Milewicz, D.M., MYh11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin ii (2007) Hum Mol Genet, 16, pp. 2453-2462
Zarrei, M., MacDonald, J.R., Merico, D., Scherer, S.W., A copy number variation map of the human genome (2015) Nat Rev Genet, 16, pp. 172-183
